Condition
Medication Assisted Treatment
Total Trials
5
Recruiting
1
Active
2
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
100%
2 of 2 completed with results
Key Signals
2 with results67% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (4)
P 4 (1)
Trial Status
Completed2
Recruiting1
Active Not Recruiting1
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05363371Not ApplicableActive Not Recruiting
Minds and Mentors Program- R33
NCT04433975Not ApplicableCompleted
Psychosocial Pain Management to Improve Opioid Use Disorder Treatment Outcomes
NCT05260047Not ApplicableRecruiting
Culturally Responsive Community Driven Substance Use Recovery for Black and Latinx Population
NCT04233671Not ApplicableCompleted
Minds and Mentors Program (MiMP)- R61
NCT04033562Phase 4Terminated
The Analgesic Efficacy of Continuous Sub-fascial Bupivacaine Infusion and Lidocaine Patches in Post-cesarean Patients With Opiate Use Disorder: A Comparative Efficacy Analysis
Showing all 5 trials